(Q30308009)

16 June 2017

title

Radionuclide evaluation of patients with lymphoma (English)

1 reference

16 June 2017

Rehm PK

1

1 reference

16 June 2017

publication date

1 September 2001

1 reference

Radiologic Clinics of North America

16 June 2017

published in

1 reference

16 June 2017

volume

39

1 reference

16 June 2017

issue

5

1 reference

16 June 2017

page(s)

957-978

1 reference

Effect of gallium nitrate therapy on Ga-67 scintigraphic detection of lymphoma: case report

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

High-dose gallium imaging in lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Benign causes of 18-FDG uptake on whole body imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

F-18-FDG uptake in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

A comparison of 111In-octreotide and 67Ga scintigraphy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

A revolution in the treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Altered 67Ga citrate distribution in patients with multiple red blood cell transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Ga-67 scintigraphy with a dual-head camera

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Lymphoma: predictive value of Ga-67 scintigraphy after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Ga-67 SPECT before and after treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Hodgkin's disease: the next decade

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Gallium 67 imaging in monitoring lymphoma response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Accumulation of FDG in axillary sweat glands in hyperhidrosis: a pitfall in whole-body PET examination

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Current role of gallium scanning in the management of lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Extranodal malignant lymphoma: detection with FDG PET versus CT

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

The effect of amphotericin B on 67Ga biodistribution

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Bone lymphoma. Comparison of Tl-201 and Ga-67 citrate scintigraphy in assessment of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

The impact of FDG positron emission tomography imaging on the management of lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Ga-67 scintigraphy in pediatric patients. Comparison of extended SPECT of the chest and abdomen with planar imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Lymphoma: evaluation with Ga-67 SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Gallium scanning in the management of mediastinal Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970323-7

7 January 2021

10.1016/S0033-8389(05)70323-7

Identifiers

DOI

1 reference

16 June 2017

1 reference